Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
Nature Medicine1997Vol. 3(1), pp. 67–72
Citations Over TimeTop 1% of 1997 papers
Martin Citron, David Westaway, Weiming Xia, George A. Carlson, Thekla S. Diehl, Georges Lévesque, Kelly Johnson‐Wood, Michael Lee, Peter Seubert, Angela Davis, Dora Kholodenko, Ruth Motter, Robin Sherrington, Billie J. Perry, Hong Yao, Robert Strome, Ivan Lieberburg, Johanna M. Rommens, Soyeon Kim, Dale Schenk, Paul Fraser, Peter St George‐Hyslop, Dennis J. Selkoe
Related Papers
- → Neuronal Deficiency of Presenilin 1 Inhibits Amyloid Plaque Formation and Corrects Hippocampal Long-Term Potentiation But Not a Cognitive Defect of Amyloid Precursor Protein [V717I] Transgenic Mice(2002)238 cited
- → Familial Alzheimer's disease mutations inhibit γ‐secretase‐mediated liberation of β‐amyloid precursor protein carboxy‐terminal fragment(2005)60 cited
- → Metabolism of Presenilin 1: Influence of Presenilin 1 on Amyloid Precursor Protein Processing(1998)8 cited
- → The value of transgenic and gene targeted models for experimental therapeutics of Alzheimer's disease(2002)
- Interaction between presenilins and amyloid precursor protein and production of the A_β(1999)